Medical Patent News

RSS

ARIUS Research granted two new U.S. patents for antibodies

ARIUS Research has announced that it has been granted two new United States patents for antibodies within their CD63 program. Patent 7,175,846. covers anti-cancer antibodies in ARIUS' partnered program for melanoma, breast and prostate cancers and protects the valuable site on the disease target that the drug candidate binds to.

8 Mar 2007

Novartis to continue Indian patent fight

Novartis CEO Daniel Vasella on Tuesday at the company's annual general meeting said that the drug maker plans to continue a lawsuit challenging a section of India's Patents Act that aims to restrict certain kinds of patents, despite criticism from some HIV/AIDS advocacy groups and shareholders, Reuters reports

8 Mar 2007

Bold proposal to restructure drug development patents

Weill Cornell Medical College scientist Dr. Carl Nathan has issued a bold call for reforming the pharmaceutical development and patent systems in order to increase the number of vaccines and drugs available to combat neglected diseases that are ravaging the world's poor.

8 Mar 2007

QLT settles Massachusetts Eye and Ear Infirmary patent lawsuit

QLT Inc. announced that the parties have settled the litigation brought in 2001 by Massachusetts Eye and Ear Infirmary ("MEEI") against QLT and Novartis Ophthalmics, Inc., case # 01-10747, in the United States District Court for the District of Massachusetts (the "District Court").

5 Mar 2007

IntraLase settles patent litigation with Escalon Medical

IntraLase Corp. has announced that it has entered into an agreement with Escalon Medical Corp. to settle all outstanding disputes and litigation between the parties.

28 Feb 2007

Court rules Synergetics product infringes IRIDEX patent

IRIDEX Corporation has announced that the Hon. Catherine Perry, United States District Judge, granted summary judgment to IRIDEX on its claim that Synergetics, Inc.'s adapter-based connector systems infringe 12 separate claims of IRIDEX's Patent No. 5,085,492.

27 Feb 2007

Pfizer wins Norvasc patent challenge by Mylan

Pfizer said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the company's U.S. patent covering the active ingredient in Norvasc

27 Feb 2007

SpectraScience granted European patent

SpectraScience, Inc. has announced that it has received the official decision for the grant of another European Patent number 1063921 for its "Optical Biopsy Forceps System and Method of Sampling Tissue."

27 Feb 2007

Spectranetics announces unfavorable jury verdict in a patent litigation dispute

Spectranetics Corporation has announced that it has received an unfavorable jury verdict in a patent litigation dispute with Dr. Peter Rentrop in the U.S. District Court in the Southern District of New York. Spectranetics has filed several post-trial motions seeking to overturn the verdict.

21 Feb 2007

Clarient receives patent for "automated detection of objects in a biological sample"

Clarient, Inc. has announced that it has been granted a new U.S. patent related to the detection and quantification of rare tumor cells in blood and bone marrow.

21 Feb 2007

Provectus receives notice of allowance for acne product

Provectus Pharmaceuticals, Inc. announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application covering novel acne medications, including the Company's invisible, solid acne treatment, Pure-Stick, which is an over- the-counter (OTC) product.

21 Feb 2007

Synergetics provides update on Iridex patent case

Synergetics USA, Inc. today announced updates to its shareholders on the status of the pending Iridex patent infringement lawsuit.

21 Feb 2007

Genentech updates on Cabilly patent peexamination

Genentech, Inc. has announced today that the U.S. Patent and Trademark Office issued a final Office action in its reexamination of the Cabilly, et al. U.S. Patent No. 6,331,415 ('415 patent) and rejected the patentability of the claims of the '415 patent.

21 Feb 2007

Expert questions validity of genetic testing patents

Molecular Pathologist-Attorney Roger D. Klein in a letter published in the February 15, 2007 issue of the New England Journal of Medicine questioned the validity of patents often used to prevent clinical laboratories from performing certain genetic tests.

20 Feb 2007

New patented technology for next generation of DNA and RNA microarrays

A novel invention developed by a scientist from New York Institute of Technology (NYIT) could revolutionize biological and clinical research and may lead to treatments for cancer, AIDS, Alzheimer's, diabetes, and genetic and infectious diseases.

13 Feb 2007

BrainLAB wins patent lawsuit

The U.S. Court of Appeals for the Federal Circuit has upheld the dismissal of the patent infringement lawsuit filed by Medtronic against BrainLAB AG in 1998.

11 Feb 2007

QLT USA settles U.S. patent litigation

QLT Inc. announced that its wholly-owned subsidiary, QLT USA, Inc. (formerly Atrix Laboratories, Inc.) has reached an agreement to settle the litigation captioned "TAP Pharmaceutical Products Inc., Takeda Chemical Industries, Ltd. and Wako Pure Chemical Industries, Ltd. v. Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc.," # 03-C-7822, United States District Court for the Northern District of Illinois and the appeal pending therefrom in the United States Court of Appeals for the Federal Circuit.

11 Feb 2007